| Compound ID |
Cluster
|
Compound Type
|
Target/Cell | Structure | Activity | Assay Description | Source | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Type
|
Relation
|
Value
|
Unit
|
||||||||
| NAs.001182 | 2 | all-match | SARS-CoV-2 |  |
Other | = | -1.83 | % | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging | CHEMBL4303101 | |
| NAs.001182 | 2 | all-match | Replicase polyprotein 1ab | |
Other | = | 32.39 | % | SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate | CHEMBL4495564 | |
| NAs.001182 | 2 | all-match | SARS-CoV-2 | |
Other | = | 0.12 | % | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging | CHEMBL4495565 | |
| NAs.001182 | 2 | all-match | SARS-CoV-2 | |
Other | = | 0.12 | % | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging | CHEMBL4495565 | |